Enhancing Postmarketing Surveillance of Medical Products With Large Language Models
Michael E. Matheny +12 more
openalex +1 more source
Dose Optimization in Oncology Drug Development: Risk Factors for Postmarketing Requirements and Commitments. [PDF]
Kitagaki H, Takeda K, Murai K, Maeda H.
europepmc +1 more source
Safety Evaluation of Omniscan: An Observational Postmarketing Surveillance. [PDF]
Mahajan H +9 more
europepmc +1 more source
Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance [PDF]
Ritsue Sasaki +6 more
openalex +1 more source
Characteristics, clinical evidence and implementation effects of conditional approvals for drugs in China, a pooled analysis from 2020 to 2023. [PDF]
Yang L +5 more
europepmc +1 more source
Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated Approval.
Mooghali M +4 more
europepmc +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Xiong X, Chen Z, Yan B.
europepmc +1 more source
Postmarketing Surveillance of Thrombectomy Using a Tron FX Stent Retriever for Large and Medium Vessel Occlusion. [PDF]
Imamura H +16 more
europepmc +1 more source

